Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Single Arm, Open Label Study to Evaluate the Efficacy and Safety of AK104 in Subjects With Recurrent or Metastatic Cervical Cancer

NCT04380805 is registered in ClinicalTrials.gov with Akeso as lead sponsor.

NCT NCT04380805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04380805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Single Arm, Open Label Study to Evaluate the Efficacy and Safety of AK104 in Subjects With Recurrent or Metastatic Cervical Cancer
Lead sponsor
Akeso
Phase
Phase 2
Overall status
Completed
Start date
July 15, 2020
Completion date
January 31, 2023
Enrollment
30 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cervical cancer, recurrent cervical cancer